ArticleCancer immunology, immunotherapy : CII2026
Targeting Blimp-1 in T cells results in activation of T-bet-mediated control of immunosuppression in lung cancer.
Susetta Finotto et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.